Pikal Michael J, Rigsbee Daniel, Roy Michael L
School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269-3092, USA.
J Pharm Sci. 2008 Dec;97(12):5122-31. doi: 10.1002/jps.21386.
This research is a study of the changes in secondary structure (Fourier transform infrared spectroscopy, FTIR), aggregation, and loss of the magnitude of the heat of denaturation upon scanning to and partially through the temperature range of the thermal denaturation peak of a model protein, human growth hormone (hGH). We study two formulations, a system of essentially pure protein (with a trace of phosphate buffer) and a system formulated with trehalose in a 3:1 trehalose:hGH weight ratio. The extent of denaturation is measured by loss of secondary structure by FTIR, the loss of heat of denaturation by differential scanning calorimetry (DSC), and the fraction of protein aggregated by HPLC. We examine loss of structure on heating to the DSC onset of thermal denaturation and restoration of structure by cooling below the denaturation temperature and holding to (nominally) allow time for refolding, and we also examine restoration of structure upon dissolving and refreeze drying samples heated to selected temperatures in the denaturation range. We find that denaturation occurs only above the glass transition temperature, is highly cooperative, and is only reversible by redissolving the "denatured" formulated (trehalose) solid. Further, all measures of the extent of denaturation are in essential agreement.
本研究是关于二级结构变化(傅里叶变换红外光谱法,FTIR)、聚集以及在扫描至并部分通过模型蛋白人生长激素(hGH)热变性峰的温度范围时变性热大小损失的研究。我们研究了两种制剂,一种是基本纯蛋白体系(含有微量磷酸盐缓冲液),另一种是以海藻糖与hGH重量比为3:1配制的海藻糖体系。变性程度通过FTIR测定二级结构的损失、差示扫描量热法(DSC)测定变性热的损失以及高效液相色谱法(HPLC)测定聚集的蛋白比例来衡量。我们研究了加热至DSC热变性起始温度时结构的损失以及冷却至变性温度以下并保持(名义上)以留出重折叠时间时结构的恢复情况,并且我们还研究了将加热至变性范围内选定温度的样品溶解并冻干后结构的恢复情况。我们发现变性仅发生在玻璃化转变温度以上,具有高度协同性,并且只有通过重新溶解“变性”的配制(海藻糖)固体才是可逆的。此外,所有变性程度的测量结果基本一致。